Treatment of Helicobacter pylori infection 2017

An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay

(2017) Cristina Dacoll et al.   Gastroenterologia y Hepatologia

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

(2017) Joo Hyun Lim et al.   Gut and Liver

Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years

(2017) Lan Li et al.   HELICOBACTER

Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin

(2017) Shoko Ono et al.   HELICOBACTER

Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis

(2017) Yoon Suk Jung et al.   HELICOBACTER

Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies

(2017) Javier P. Gisbert et al.   HELICOBACTER

New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori : A first Italian experience in clinical practice

(2017) Antonio Tursi et al.   HELICOBACTER

A prospective evaluation of levofloxacin-based triple therapy for refractory Helicobacter pylori infection in Australia

(2017) Peter H. Katelaris et al.   INTERNAL MEDICINE JOURNAL

Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment ofHelicobacter pyloriinfection

(2017) Sung Min Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection

(2017) Jing Su et al.   MEDICINE

Helicobacter pylori eradication in the Swedish population

(2017) Eva Doorakkers et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance

(2017) Ayhan Hilmi Cekin et al.   Turkish Journal of Gastroenterology

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy

(2017) Kouichi Sakurai et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes

(2017) Sung Eun Kim et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Clarithromycin resistance in Helicobacter pylori and its molecular determinants in Northern Spain, 2013–2015

(2017) Esther Tamayo et al.   Journal of Global Antimicrobial Resistance

Antibiotic susceptibility of Helicobacter pylori in Iceland

(2017) Anna Ingibjorg Gunnarsdottir et al.   Infectious Diseases

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

(2017) Kevin F Boehnke et al.   Infection and Drug Resistance

Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments ofHelicobacter pyloriinfection

(2016) P.-Y. Chen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy

(2016) Sho Suzuki et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy

(2016) Qi Chen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection

(2016) Li Feng et al.   AMERICAN JOURNAL OF THERAPEUTICS

Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial

(2016) Ju Yup Lee et al.   BMC GASTROENTEROLOGY

Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis

(2016) Yiqiao Xin et al.   BMC GASTROENTEROLOGY

Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal

(2016) Muhammad Miftahussurur et al.   BMC MICROBIOLOGY

Hybrid Therapy Regimen for Helicobacter Pylori Eradication

(2016) Li-Ya Zhou et al.   CHINESE MEDICAL JOURNAL

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods

(2016) A. Ducournau et al.   CLINICAL MICROBIOLOGY AND INFECTION

Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy

(2016) Zhiqiang Song et al.   DIGESTIVE AND LIVER DISEASE

The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use

(2016) Sun Gyo Lim et al.   DIGESTIVE AND LIVER DISEASE

Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study

(2016) Jun-Won Chung et al.   DIGESTIVE AND LIVER DISEASE

Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance

(2016) Hiroshi Matsumoto et al.   DIGESTIVE DISEASES AND SCIENCES

Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA

(2016) Jason Y. Park et al.   DIGESTIVE DISEASES AND SCIENCES

Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication

(2016) Bojan Tepeš et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area

(2016) Sotirios D. Georgopoulos et al.   European Journal of Internal Medicine

Triple terapia 10 días con esomeprazol 40 mg/12 h vs. cuádruple concomitante sin bismuto como tratamiento de primera línea de la infección por Helicobacter pylori

(2016) Ana Campillo et al.   Gastroenterologia y Hepatologia

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

(2016) Carlo A. Fallone et al.   GASTROENTEROLOGY

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study

(2016) Kazunari Murakami et al.   GUT

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

First-lineHelicobacter pylorieradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis

(2016) Yee Hui Yeo et al.   GUT

Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial

(2016) Hyuk Yoon et al.   Gut and Liver

Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

(2016) Joon Sung Kim et al.   Gut and Liver

Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection withHelicobacter pyloriin Japan

(2016) Mitsushige Sugimoto et al.   HELICOBACTER

High antibiotic resistance ofHelicobacter pyloriand its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland

(2016) Stanisław Ferenc et al.   HELICOBACTER

Increasing metronidazole and rifampicin resistance ofHelicobacter pyloriisolates obtained from children and adolescents between 2002 and 2015 in southwest Germany

(2016) Thomas Regnath et al.   HELICOBACTER

Hybrid Therapy as First-Line Regimen forHelicobacter pyloriEradication in Populations with High Antibiotic Resistance Rates

(2016) Zhiqiang Song et al.   HELICOBACTER

Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies

(2016) Antonio Francesco Ciccaglione et al.   HELICOBACTER

Rabeprazole, Minocycline, Amoxicillin, and Bismuth as First-Line and Second-Line Regimens forHelicobacter pyloriEradication

(2016) Zhiqiang Song et al.   HELICOBACTER

Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis

(2016) Judit Alarcón-Millán et al.   INFECTION GENETICS AND EVOLUTION

Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen

(2016) Yoshihiro Hirata et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Primary resistance of Helicobacter pylori is still low in Southern Austria

(2016) Ines Zollner-Schwetz et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatment

(2016) Ignasi Puig et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial

(2016) Junbo Hong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori

(2016) Giulia Fiorini et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens forHelicobacter pylorieradication

(2016) Zhi Qiang Song et al.   Journal of Digestive Diseases

Efficacy and safety of high-dose dual therapy forHelicobacter pylorirescue therapy: A systematic review and meta-analysis

(2016) Cai Ping Gao et al.   Journal of Digestive Diseases

Vonoprazanversusconventional proton pump inhibitor-based triple therapy as first-line treatment againstHelicobacter pylori: A multicenter retrospective study in clinical practice

(2016) Satoki Shichijo et al.   Journal of Digestive Diseases

Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori

(2016) Satoshi Shinozaki et al.   KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2016) Jyh-Ming Liou et al.   LANCET

Helicobacter pylori resistance to clarithromycin in Reunion Island

(2016) N. Zemali et al.   MEDECINE ET MALADIES INFECTIEUSES

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication

(2016) Seng-Kee Chuah et al.   MEDICINE

High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication

(2016) Laleh Mahmoudi et al.   MEDICINE

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication

(2016) Sherief Abd-Elsalam et al.   MEDICINE

High-Level Primary Clarithromycin Resistance ofHelicobacter pyloriin Algiers, Algeria: A Prospective Multicenter Molecular Study

(2016) Fazia Djennane-Hadibi et al.   Microbial Drug Resistance

Helicobacter pylori Primary Antibiotic Resistance in 2015 in Morocco: A Phenotypic and Genotypic Prospective and Multicenter Study

(2016) Najat Bouihat et al.   Microbial Drug Resistance

Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014)

(2016) Alba A. Trespalacios-Rangél et al.   PLoS One

Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials

(2016) Muhan LÜ et al.   PLoS One

Analysis of the cost-effectiveness of using vonoprazan–amoxicillin–clarithromycin triple therapy for first-line Helicobacter pylori eradication

(2016) Yusaku Kajihara et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Hybrid, sequential and concomitant therapies forHelicobacter pylorieradication: A systematic review and meta-analysis

(2016) Zhi-Qiang Song et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Nonbismuth concomitant quadruple therapy forHelicobacter pylorieradication in Chinese regions: A meta-analysis of randomized controlled trials

(2016) Lien-Chieh Lin et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Detection ofHelicobacter pyloriresistance to clarithromycin and fluoroquinolones in Brazil: A national survey

(2016) Bruno Squarcio Sanches et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Molecular detection of Helicobacter pylori antibiotic resistance in stool vs biopsy samples

(2016) Denise E Brennan et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Multicenter Study of Antibiotic Resistance Profile ofH. pyloriand Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China

(2016) Ran Han et al.   Gastroenterology Research and Practice

High Dose Ilaprazole/Amoxicillin as First-Line Regimen forHelicobacter pyloriInfection in Korea

(2016) WonGun Kwack et al.   Gastroenterology Research and Practice

Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains

(2016) Nelly Muller et al.   Clinics and Research in Hepatology and Gastroenterology

Sequential versus concomitant therapy for eradication of Helicobacter Pylori in patients with perforated duodenal ulcer: A randomized trial

(2016) Vikram Kate et al.   Saudi Journal of Gastroenterology

Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori

(2016) Murat Kekilli et al.   Saudi Journal of Gastroenterology

Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection

(2016) Ignasi Puig et al.   Therapeutic Advances in Gastroenterology

Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients

(2016) Daisuke Fukuda et al.   Therapeutic Advances in Gastroenterology

Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events

(2016) Lynne V McFarland et al.   United European Gastroenterology Journal

Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients

(2016) Adnan Abuhammour et al.   Arab Journal of Gastroenterology

Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis

(2016) Christine Lau et al.   Infection and Drug Resistance

Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study

(2016) Hong-Mo Shih et al.   PLoS One

Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations

(2016) Muhammad Miftahussurur et al.   PLoS One

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication ofHelicobacter pyloriin the community and hospital populations: a randomised trial

(2015) Jyh-Ming Liou et al.   GUT

Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies forHelicobacter pyloriStrains Containing thegyrAMutation

(2015) Hideki Mori et al.   HELICOBACTER

The Effect of Probiotics on Gut Microbiota during theHelicobacter pyloriEradication: Randomized Controlled Trial

(2015) Bumjo Oh et al.   HELICOBACTER

Eradication Rates ofHelicobacter pyloriin Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey

(2015) Woon Geon Shin et al.   HELICOBACTER

Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study

(2015) Hideki Mori et al.   United European Gastroenterology Journal

Practical treatment of Helicobacter pylori

(2014) Sinéad M. Smith et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS